963 — Asheville, North Carolina

963 is a clinical research site located in Asheville, North Carolina, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

963 has participated in 2 clinical trials.

Therapeutic areas: Arthritis, Psoriatic, Spondyloarthropathies.

Sponsors: UCB BIOSCIENCES GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Asheville

Browse all research sites in North Carolina · View every site in Asheville

• Asheville VA Medical Center, Asheville, NC
• Mission Hospitals - Memorial Campus
• Mission Hospital/Asheville Heart
• Veterans Affairs Medical Center - Asheville
• Memorial Mission Hospital
• Mission Neurology, Research Institute Mission Hospital, 509 Biltmore
• Mission Hospital - St. Joseph ( Site 2015)
• University of North Carolina Health Sciences at MAHEC
• Mission Hospitals Research Institute
• Fullerton Genetics Center-Mission, St. Joseph's Hospital
• Mission Hospital/Mission Neurology Services
• MH Mission Hospital, LLLP

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 963?

963 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 963 conducted?

963 has 2 clinical trials on record. Their work covers Arthritis, Psoriatic, Spondyloarthropathies.

Is 963 accredited by Crixeo Clinical Trials?

963 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 963?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.